(Circulation. 1995;92:2391-2395.)
© 1995 American Heart Association, Inc.
Articles |
From the University of Nebraska Medical Center, Omaha.
Correspondence to Thomas R. Porter, MD, University of Nebraska Medical Center, Section of Cardiology, Omaha, NE 68198-1165.
| Abstract |
|---|
|
|
|---|
Methods and Results In 14 dogs, the myocardial contrast intensity produced by transient-response imaging (TRI) was compared with conventional 30-Hz imaging (CI) after a 0.005 to 0.030 mL/kg intravenous injection of PESDA. TRI was produced either by measuring myocardial contrast during triggered (1 pulse per cardiac cycle) ultrasound or by withholding real time ultrasound transmission until after microbubbles had entered the myocardium after intravenous injection. Both first-harmonic imaging (2.0 to 3.5 MHz) and second-harmonic imaging (2.0 to 2.5 MHz fundamental, 4.0 to 5.0 MHz received) were used. TRI produced over three times the anterior myocardial contrast intensity of CI (36±12 U TRI versus 11±11 U CI; P<.01), with visually better anterior and posterior myocardial contrast. The spatial extent of myocardial ischemia was easily visualized after intravenous PESDA by use of TRI and correlated closely with risk area as measured with Monastral blue (r=.99, P=.002).
Conclusions TRI produces significantly greater myocardial contrast than CI and may dramatically enhance the ability of intravenous ultrasound contrast agents to identify myocardial perfusion abnormalities.
Key Words: ultrasonics imaging contrast media
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Ultrasound images in seven dogs were obtained using a 2.0-, 2.5-, or 3.5-MHz ultrasound transducer connected to a commercially available scanner (Hewlett-Packard Sonos 1500). The peak negative pressure generated by these transducers at the acoustic output used in this study at a focal depth of 4 to 6 cm is 0.8 Megapascals, and the spatial peak pulse average intensity is 66 W/cm2. Whereas tissue and blood reflect ultrasound at the transmitted or fundamental frequency, microbubbles undergo both linear and nonlinear oscillations in the presence of ultrasound. These have been referred to as harmonics,7 and in seven dogs in this study, a prototype transducer connected to a Hewlett-Packard Sonos 2500 scanner was used to study this phenomenon. This transducer transmitted at 2.0-MHz (4.0-MHz received frequency) in six dogs and 2.5-MHz (5.0-MHz received frequency) in two dogs.
The transducer was placed in a warm-water bath overlying the anterior surface of the heart and positioned to produce a short-axis view of the left ventricle at the midpapillary muscle level. A 2-0 silk ligature was placed around either the left anterior descending or left circumflex artery in eight of the dogs to create a critical coronary narrowing (>50% diameter by quantitative angiography). In five of these dogs, this same ligature was also used to create total vessel occlusion.
Study Protocol
Both PESDA and room aircontaining
sonicated dextrose
albumin were prepared by methods similar to those previously
described.8 Briefly, 8 mL of perfluorobutane or room air
were hand-agitated with a 3:1 mixture of 5% dextrose with 5%
human albumin. This mixture then underwent electromechanical
sonication for 80 seconds.
To test how much better the transient contrast produced by brief or gated exposure to pulsed ultrasound (transient-response imaging, or TRI) was than conventional imaging, the protocol was performed in one of two ways. One method involved measuring the peak myocardial videointensity observed in real time immediately after freezing transducer output for 10 to 60 seconds after intravenous injection of a low dose (0.005 to 0.03 mL/kg) of PESDA (method 1). This interval was computed from a previous test injection that counted the time required for contrast to reach the myocardium after venous injection and for acoustic shadowing in the left ventricular cavity to resolve. A second method of producing transient contrast enhancement was employed by delivering ultrasound pulses gated (triggered) to only one part of the cardiac cycle (method 2).
In six of the dogs in the study, the peak myocardial videointensity produced by TRI of intravenous room aircontaining sonicated dextrose albumin was also determined. Four of these determinations were made with second-harmonic imaging, and two were made with first-harmonic imaging.
In 4 dogs, comparisons of anterior (left anterior descending artery distribution) and posterior (left circumflex distribution) peak myocardial videointensity between conventional imaging and TRI were performed by use of the second harmonic, whereas comparisons of TRI with conventional imaging in the first harmonic were performed in 10 dogs. Comparisons of TRI with conventional imaging were made under baseline conditions and during alterations in coronary flow produced by a coronary stenosis (>50% diameter by quantitative angiography) during incremental dobutamine stress in 7-minute stages of 5, 10, 20, and 30 µg · kg-1 · min-1. In 5 dogs, a final injection of PESDA was given after total occlusion of the coronary vessel. The contrast defect observed with TRI in these dogs was compared with the planimetered risk area as determined by use of Monastral blue staining as previously described.9
Background-subtracted peak myocardial videointensity (PMVI) from the midanterior and posterior portions of the myocardium (corresponding to left anterior descending and left circumflex perfusion beds) was measured off-line at end-systole from high-fidelity videotape images. Gray-scale software (Tom-Tec Review Station), which quantifies videointensity (0 to 255 scale) versus time, was used to measure the contrast intensity. Instrument settings, as well as intravenous PESDA dose, were kept constant in each dog for each comparison. Visual grading of myocardial contrast enhancement produced by TRI versus conventional imaging in both the anterior and posterior myocardium was assessed in eight dogs using a scale of 0 (no contrast enhancement), 1+ (mild contrast enhancement), and 2+ (bright contrast enhancement). Although these measurements were made in an unblinded manner, interobserver variability on these visual measurements was determined by comparing myocardial contrast intensity as measured by two independent, experienced observers following 12 injections in three dogs. The comparison of PMVI produced with TRI versus conventional imaging was evaluated by use of a Mann-Whitney rank sum test. When second-harmonic imaging was available, comparisons of PMVI produced by conventional imaging and TRI with the first versus the second harmonic were made by use of ANOVA. Comparisons of the myocardial contrast produced by room aircontaining sonicated dextrose albumin and PESDA with TRI were made by use of unpaired t testing. Contingency tables were created to compare differences in visual grading of myocardial contrast. Linear regression was used to compare area at risk with TRI and risk area as determined by use of Monastral blue and to compare coronary flow with PMVI using TRI.
| Results |
|---|
|
|
|---|
In the dogs in which second-harmonic imaging was available, TRI
made by use of the first versus the second harmonic was compared with
conventional first-harmonic and second-harmonic imaging
(Table
). Fig 1
shows sonograms taken
after an intravenous injection of PESDA at peak intensity
made by use of conventional imaging compared with TRI under baseline
conditions. In both first- and second-harmonic imaging, the
myocardial contrast seen with TRI was three to seven times greater than
conventional 30-Hz frame rate imaging (Table
). The low dose of
PESDA
required to produce this contrast with TRI (0.005 to 0.01 mL/kg) also
prevented acoustic shadowing from left ventricular cavity
contrast. When the peak anterior myocardial videointensity produced by
TRI in the first and second harmonic were compared, there was
significantly higher contrast with the second harmonic (23±8 for
first-harmonic TRI versus 60±25 for second-harmonic TRI;
P<.001).
|
|
The duration of transient myocardial contrast in real time using method
1 averaged 3.3±2.4 seconds (Fig 2A
). When method 2 was
used (triggered pulses once per cardiac cycle), the peak myocardial
contrast was just as high as for method 1 (47±19 U for method 2 versus
46±23 U for method 1; n=16 comparisons) but was demonstrable for
the
entire injection period. An example of this is shown in Fig 2
,
in which the same dose of PESDA is given twice in
the same dog, once using method 1 and once using method 2. Because
method 2 delivered a frame each cardiac cycle beginning immediately
after injection, the increased contrast with TRI could be demonstrated
earlier and with longer duration.
|
The visual grade of anterior myocardial contrast after intravenous PESDA was 2+ after 9 of 18 injections made by use of first-harmonic TRI and after all 8 of 8 injections made by use of second-harmonic TRI. When conventional first-harmonic imaging was used, 2+ myocardial contrast was not observed after any injection using the first harmonic and was seen after only 3 of 9 injections with second-harmonic conventional imaging (P<.001 by Fisher's exact test). The two independent reviewers agreed on the degree of visual myocardial contrast in 10 of 12 random comparisons.
Intravenous room aircontaining sonicated dextrose albumin (up to 8 mL) did not produce myocardial contrast when first-harmonic TRI was used or with conventional first- or second-harmonic imaging. In three of the four dogs when room aircontaining microbubbles were given using second-harmonic TRI, however, visually evident anterior myocardial contrast was produced. The anterior myocardial PMVI produced with 8-mL intravenous injections of room aircontaining sonicated dextrose albumin (34±24 U) was still significantly smaller than that produced with 0.005 to 0.01 mL/kg intravenous PESDA in these same dogs (83±16 U; P<.0001).
TRI During Myocardial Ischemia
A total of 21 additional
intravenous injections were
given to test the ability of TRI with intravenous PESDA to
quantify coronary flow changes. The range of coronary
flows in this group of dogs ranged from 0 (during total occlusion) to
172 mL/min (peak dobutamine stress). The range of peak
myocardial videointensities after intravenous PESDA with
TRI under these conditions ranged from 0 to 100 U. There was a good
correlation within dogs between peak videointensity as measured by TRI
and coronary flow (mean correlation coefficient, .87; range,
0.79 to 0.94). Despite the higher peak videointensity seen with
second-harmonic TRI, the correlation with coronary flow was
good for both harmonics (r=.87, first harmonic;
r=.87, second harmonic; P<.01 for both).
In
the five dogs in which Monastral blue was given during acute
ischemia, the stain could be visualized in four. In one dog,
the Monastral blue did not stain any region of myocardium,
and this dog was excluded from analysis. In the remaining four
dogs, there was a close correlation between risk area as measured with
Monastral blue and that measured with TRI (r=.99;
P<.001; range of risk areas, 4.0 to 7.4 cm2).
Fig 3
demonstrates area at risk using first- and
second-harmonic TRI in two dogs during left circumflex
ischemia.
|
| Discussion |
|---|
|
|
|---|
The significantly increased myocardial contrast with TRI may occur for
one of two reasons. The first possibility is that transient cavitation
is occurring, similar to that which has been seen in vitro with
sonicated albumin. Transient increases in sonicated
albumin microbubble size occur in the presence of conventional
ultrasound transmission.10 These increases in microbubble
size have been brief (milliseconds in duration), followed by a return
to steady state. Since microbubble reflectance is exponentially related
to its size, this would result in transient contrast enhancement.
Although the duration of transient cavitation observed in vitro with
sonicated albumin was much shorter than the duration of
increased contrast we observed, there are two potential reasons why
transient cavitation may have lasted longer with the microbubbles used
in the present study. First, we could not detect transient contrast
in the first harmonic with our room aircontaining microbubbles
but were able to identify it with fluorocarbon-containing
microbubbles. It is possible that these less-soluble gases may
prolong the duration of transient cavitation. Next, harmonic resonances
have been observed with microbubbles that transiently cavitate in
response to diagnostic ultrasound.2 This may
explain why we also observed transient myocardial contrast when a
second-harmonic frequency was used (Table
).
Another explanation for the transient contrast may be that standard-imaging pulse rates destroy the microbubbles. By delaying ultrasound transmission or triggering pulses to one part of the cardiac cycle, more bubbles may reach the myocardium and hence cause greater contrast. Microbubble destruction in response to diagnostic ultrasound pressures has been observed with sonicated albumin4 5 6 but has not been detected with fluorocarbon-containing microbubbles. To distinguish between these two potential mechanisms for TRI, passive or active acoustic detection systems will need to be used that can detect whether transient cavitation of microbubbles is occurring.
Clinical Implications
TRI with intravenous ultrasound
contrast agents could
potentially overcome three limitations that presently exist with
intravenous ultrasound contrast agents. First, it produces
dramatically better myocardial contrast than what is achieved with
conventional imaging. Second, the doses required to achieve myocardial
contrast are lower and thus safer than what is required for
conventional imaging. Finally, because much lower doses of
intravenous contrast are required, it reduces the amount of
posterior myocardial attenuation caused by left ventricular
cavity contrast.
The peak myocardial contrast produced by TRI was able
to delineate
resting and stress-induced coronary flow changes (Fig 3
). Peak
myocardial videointensity with TRI correlated
with flow in these situations because changes in flow were induced by
changes in myocardial blood volume, and it has been demonstrated that
peak videointensity correlates more closely with myocardial blood
volume than with flow.11 Additionally, the improved
contrast signal obtained with TRI could be used to visualize more
easily the risk area or regions of relative hypoperfusion and thus
improve the detection of coronary artery disease and
quantification of the spatial extent of ischemic
burden.12 It may also delineate regions of no reflow after
successful reperfusion and thus improve previous methods of detecting
myocardial viability with intravenously injected ultrasound
contrast.13
In conclusion, dramatically improved myocardial ultrasound contrast can be produced with very low doses of intravenous PESDA by use of TRI. Further in vivo study is needed to determine the mechanism of this phenomenon, as well as to apply this imaging modality to transthoracic imaging in humans.
| Acknowledgments |
|---|
Received June 29, 1995; revision received September 6, 1995; accepted September 8, 1995.
| References |
|---|
|
|
|---|
2. Flynn HG, Church CC. Transient pulsations of small gas bubbles in water. J Acoust Soc Am. 1988;84:1863-1876. Erratum. [Medline] [Order article via Infotrieve]
3. Crum LA, Roy RA, Dinno MA, Church CC. Acoustic cavitation produced by microsecond pulses of ultrasound: a discussion of some selected results. J Acoust Soc Am. 1992;91:1113-1119. [Medline] [Order article via Infotrieve]
4. Mor-Avi V, Robinson K, Shroff S, Lang RM. Stability of albunex microspheres under ultrasonic irradiation: an in vitro study. J Am Soc Echocardiogr. 1994;7:S29.
5. Vandenberg BF, Melton HE. Acoustic liability of albumin microspheres. J Am Soc Echocardiogr. 1994;7:582-589. [Medline] [Order article via Infotrieve]
6. Wray RA, Zoghbi WA, Quinones MA, Cheirif J. Contrast echocardiography: relation of acoustic power and time gain compensation to contrast intensity duration. J Am Soc Echocardiogr. 1992;4:286.
7. Schrope BA, Newhouse VL. Second harmonic ultrasound blood perfusion measurement. Ultrasound Med Biol. 1993;19:567-579. [Medline] [Order article via Infotrieve]
8. Porter TR, Xie F, Kilzer K. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial contrast which correlates with coronary blood flow. J Am Soc Echocardiogr. 1995;8:710-718. [Medline] [Order article via Infotrieve]
9. Sakamaki T, Tei C, Meerbaum S, Shimoura K, Kondo S, Fishbein MC, Y Rit J, Shah PM, Corday E. Verification of myocardial contrast two-dimensional echocardiographic assessment of perfusion defects in ischemic myocardium. J Am Coll Cardiol. 1984;3:34-38. [Abstract]
10. Roy RA, Church CC, Calabrese A. Cavitation produced by short pulses of ultrasound. In: Hamilton AF, Blackstock DT, eds. Frontiers of Nonlinear Acoustics: Proceedings of 12th International Symposium of Nonlinear Acoustics. London: Elsevier Science Publishing Co; 1990:476-481.
11.
Skyba DM, Jayaweera AR, Goodman NC.
Quantification of myocardial contrast
echocardiography during left atrial injection of
contrast: implications for venous injection.
Circulation. 1994;90:1513.
12.
Ismail S, Jayaweera AR, Goodman NC, Camarano GP, Skyba
DM, Kaul S. Detection of coronary stenoses and
quantification of the degree and spatial extent of blood flow mismatch
during coronary hyperemia with myocardial contrast
echocardiography.
Circulation. 1995;91:821-830.
13.
Villanueva FS, Glasheen WP, Sklenar J, Kaul S.
Characterization of spatial patterns of flow within the reperfused
myocardium by myocardial contrast
echocardiography: implications in determining
extent of myocardial salvage. Circulation. 1993;88:2596-2606.
This article has been cited by other articles:
![]() |
E. Bartels and H.-J. Bittermann Transcranial Contrast Imaging of Cerebral Perfusion in Patients With Space-Occupying Intracranial Lesions J. Ultrasound Med., April 1, 2006; 25(4): 499 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Forsberg, W. T. Shi, C. R. B. Merritt, Q. Dai, M. Solcova, and B. B. Goldberg On the Usefulness of the Mechanical Index Displayed on Clinical Ultrasound Scanners for Predicting Contrast Microbubble Destruction J. Ultrasound Med., April 1, 2005; 24(4): 443 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Seidel, K. Meyer-Wiethe, G. Berdien, D. Hollstein, D. Toth, and T. Aach Ultrasound Perfusion Imaging in Acute Middle Cerebral Artery Infarction Predicts Outcome Stroke, May 1, 2004; 35(5): 1107 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wiesmann, K. Meyer, T. Albers, and G. Seidel Parametric Perfusion Imaging With Contrast-Enhanced Ultrasound in Acute Ischemic Stroke Stroke, February 1, 2004; 35(2): 508 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Masugata, N. Fujita, I. Kondo, B. Peters, K. Ohmori, K. Mizushige, M. Kohno, and A. N. DeMaria Assessment of right ventricular perfusion after right coronary artery occlusion by myocardial contrast echocardiography J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1823 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Stewart CONTRAST ECHOCARDIOGRAPHY Heart, March 1, 2003; 89(3): 342 - 348. [Full Text] [PDF] |
||||
![]() |
J. U. Harrer and C. Klotzsch Second Harmonic Imaging of the Human Brain: The Practicability of Coronal Insonation Planes and Alternative Perfusion Parameters Stroke, June 1, 2002; 33(6): 1530 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Andrassy, M Zielinska, R Busch, A Schomig, and C Firschke Myocardial blood volume and the amount of viable myocardium early after mechanical reperfusion of acute myocardial infarction: prospective study using venous contrast echocardiography Heart, April 1, 2002; 87(4): 350 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schneider Bubbles in echocardiography: climbing the learning curve Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C3 - C7. [Abstract] [PDF] |
||||
![]() |
H. Becher, K. Tiemann, S. Kuntz-Hehner, H. Omran, and T. Schlosser Diagnostic impact of contrast echocardiography for assessment of left ventricular function and myocardial perfusion in patients with coronary artery disease Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C12 - C21. [Abstract] [PDF] |
||||
![]() |
H. Masugata, S. Lafitte, B. Peters, G. M. Strachan, and A. N. DeMaria Comparison of Real-Time and Intermittent Triggered Myocardial Contrast Echocardiography for Quantification of Coronary Stenosis Severity and Transmural Perfusion Gradient Circulation, September 25, 2001; 104(13): 1550 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kuntz-Hehner, J. Goenechea, C. Pohl, T. Schlosser, C. Veltmann, C. Lentz, S. Lohmaier, A. Ehlgen, H. Omran, H. Becher, et al. Continuous-Infusion Contrast-enhanced US: In Vitro Studies of Infusion Techniques with Different Contrast Agents Radiology, September 1, 2001; 220(3): 647 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Villanueva, E. W. Gertz, M. Csikari, G. Pulido, D. Fisher, and J. Sklenar Detection of Coronary Artery Stenosis With Power Doppler Imaging Circulation, May 29, 2001; 103(21): 2624 - 2630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shimoni, W. A. Zoghbi, F. Xie, D. Kricsfeld, S. Iskander, L. Gobar, I. A. Mikati, J. Abukhalil, M. S. Verani, E. L. O'Leary, et al. Real-time assessment of myocardial perfusion and wall motion during bicycle and treadmill exercise echocardiography: comparison with single photon emission computed tomography J. Am. Coll. Cardiol., March 1, 2001; 37(3): 741 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Leistad, K. Ohmori, T. A. Peterson, G. Christensen, and A. N. DeMaria Quantitative assessment of myocardial perfusion during graded coronary artery stenoses by intravenous myocardial contrast echocardiography J. Am. Coll. Cardiol., February 1, 2001; 37(2): 624 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wiesmann and G. Seidel Ultrasound Perfusion Imaging of the Human Brain Stroke, October 1, 2000; 31(10): 2421 - 2425. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Mills, D. Fischer, and F. S. Villanueva Coronary collateral development during chronic ischemia: serial assessment using harmonic myocardial contrast echocardiography J. Am. Coll. Cardiol., August 1, 2000; 36(2): 618 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Voci The bubbles and the science of life J. Am. Coll. Cardiol., August 1, 2000; 36(2): 625 - 627. [Full Text] [PDF] |
||||
![]() |
C. Pohl, K. Tiemann, T. Schlosser, and H. Becher Stimulated Acoustic Emission Detected by Transcranial Color Doppler Ultrasound : A Contrast-Specific Phenomenon Useful for the Detection of Cerebral Tissue Perfusion Stroke, July 1, 2000; 31(7): 1661 - 1666. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Seidel, C. Algermissen, A. Christoph, T. Katzer, M. Kaps, and R. W. Baumgartner Visualization of Brain Perfusion With Harmonic Gray Scale and Power Doppler Technology : An Animal Pilot Study Editorial Comment: An Animal Pilot Study Stroke, July 1, 2000; 31(7): 1728 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Halpern, L. Verkh, F. Forsberg, L. G. Gomella, R. F. Mattrey, and B. B. Goldberg Initial Experience with Contrast-Enhanced Sonography of the Prostate Am. J. Roentgenol., June 1, 2000; 174(6): 1575 - 1580. [Abstract] [Full Text] |
||||
![]() |
G. Seidel, C. Algermissen, A. Christoph, L. Claassen, M. Vidal-Langwasser, and T. Katzer Harmonic Imaging of the Human Brain : Visualization of Brain Perfusion With Ultrasound Stroke, January 1, 2000; 31(1): 151 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Forsberg, B. B. Goldberg, J.-B. Liu, D. A. Merton, N. M. Rawool, and W. T. Shi Tissue-Specific US Contrast Agent for Evaluation of Hepatic and Splenic Parenchyma Radiology, January 1, 1999; 210(1): 125 - 132. [Abstract] [Full Text] |
||||
![]() |
L. Galiuto, A. N. DeMaria, K. May-Newman, U. del Balzo, K. Ohmori, V. Bhargava, S. F. Flaim, and S. Iliceto Evaluation of dynamic changes in microvascular flow during ischemia-reperfusion by myocardial contrast echocardiography J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1096 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Postert, A. Muhs, S. Meves, J. Federlein, H. Przuntek, and T. Buttner Transient Response Harmonic Imaging : An Ultrasound Technique Related to Brain Perfusion Stroke, September 1, 1998; 29(9): 1901 - 1907. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Grayburn, J. L. Weiss, T. C. Hack, E. Klodas, J. S. Raichlen, M. A. Vannan, A. L. Klein, D. W. Kitzman, S. G. Chrysant, J. L. Cohen, et al. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms J. Am. Coll. Cardiol., July 1, 1998; 32(1): 230 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wei, A. R. Jayaweera, S. Firoozan, A. Linka, D. M. Skyba, and S. Kaul Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion? J. Am. Coll. Cardiol., July 1, 1998; 32(1): 252 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaul Myocardial Contrast Echocardiography : 15 Years of Research and Development Circulation, November 18, 1997; 96(10): 3745 - 3760. [Full Text] |
||||
![]() |
J. Sklenar, G. Camarano, N. C. Goodman, S. Ismail, A. R. Jayaweera, and S. Kaul Contractile Versus Microvascular Reserve for the Determination of the Extent of Myocardial Salvage After Reperfusion: The Effect of Residual Coronary Stenosis Circulation, September 15, 1996; 94(6): 1430 - 1440. [Abstract] [Full Text] |
||||
![]() |
F. S. Villanueva, G. Camarano, S. Ismail, N. C. Goodman, J. Sklenar, and S. Kaul Coronary Reserve Abnormalities in the Infarcted Myocardium: Assessment of Myocardial Viability Immediately Versus Late After Reflow by Contrast Echocardiography Circulation, August 15, 1996; 94(4): 748 - 754. [Abstract] [Full Text] |
||||
![]() |
S. Ismail, A. R. Jayaweera, G. Camarano, L. W. Gimple, E. R. Powers, and S. Kaul Relation Between Air-Filled Albumin Microbubble and Red Blood Cell Rheology in the Human Myocardium: Influence of Echocardiographic Systems and Chest Wall Attenuation Circulation, August 1, 1996; 94(3): 445 - 451. [Abstract] [Full Text] |
||||
![]() |
E. J. Halpern, P. A. McCue, A. K. Aksnes, E. K. Hagen, F. Frauscher, and L. G. Gomella Contrast-enhanced US of the Prostate with Sonazoid: Comparison with Whole-Mount Prostatectomy Specimens in 12 Patients Radiology, February 1, 2002; 222(2): 361 - 366. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |